Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02994121 · ClinicalTrials.gov registry record
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
A clinical trial of Multiple Sclerosis, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 7,500
- Enrollment target
- 1
- Study location
NCT02994121 is a study of Multiple Sclerosis that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 7,500 participants, above the 561-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (1237% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02994121, a study of Multiple Sclerosis, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 7,500 participants
- Enrollment target
- 1
- Study location
Study Summary
In this longitudinal prospective natural history study of multiple sclerosis (MS), the overarching goal is to understand the factors that influence individual variation in disease trajectory and treatment response and pave the way for realizing precision medicine in MS. Because MS is a chronic neurological disorder, this observational cohort study will span a 30-year time frame.
Conditions Studied
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,500 participants |
| Start Date | 2016-12 |
| Est. Completion | 2047-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02994121
The ClinicalTrials.gov registry entry for NCT02994121 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 7,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 561-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (1237% higher). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT02994121 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02994121 about?
NCT02994121 is a clinical study titled "Prospective Investigation of Multiple Sclerosis in the Three Rivers Region". In this longitudinal prospective natural history study of multiple sclerosis (MS), the overarching goal is to understand the factors that influence individual variation in disease trajectory and treatment response and pave the way for realizing precision medicine in MS. Because MS is a chronic neuro...
What is the current status of trial NCT02994121?
This trial is currently recruiting. The enrollment target is 7,500 participants. The study started on 2016-12. Estimated completion is 2047-01.
What conditions does trial NCT02994121 study?
This clinical trial studies the following conditions: Multiple Sclerosis.
Who is sponsoring clinical trial NCT02994121?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02994121 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.